Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tensin-4 (TNS4) is a focal adhesion-associated protein encoded by the TNS4 gene in humans. It binds actin and participates in protein localization at the cell cytoskeleton and focal adhesions. Tensin-4 promotes cell migration, especially in response to EGF, by displacing tensin TNS3 from integrin ITGB1, leading to actin stress fiber disassembly and initiation of migration. It also suppresses ligand-induced degradation of EGFR by reducing EGFR ubiquitination and increases MET protein stability by inhibiting its endocytosis and lysosomal degradation, resulting in increased cell survival and proliferation. Tensin-4 is implicated in various oncogenic processes and is associated with certain cancers, particularly where cell migration and invasion are relevant[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tensin-4 (TNS4).